General public

You are here

The PETAL Network

The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL Network) is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent or treat, and/or improve the outcome of patients who have, or who are at risk for, Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS).

News

Jun 22, 2020

Major US Trial Closes Showing No Benefit for Hydroxychloroquine in COVID-19

June 20, 2020

Mar 3, 2020

On behalf of the PETAL Network, we are excited to share that two of the primary manuscripts have been published in the New England Journal of Medicine.

Aug 29, 2018

As physicians and scientists, our goal is to advance the care and treatment of sepsis, which claims the lives of more than 250,000 Americans every year. This study compares two approaches for the treatment of septic shock that are both currently in widespread use.

Dec 17, 2015

It is with the heaviest of hearts and deepest sorrow that the PETAL Network notes the passing of Arthur “Art” P. Wheeler on December 17th, 2015.

read more…